Abstract
Objectives.: The morbidity associated with pelvic exenteration is high; however, patients undergoing this procedure have no other curative treatment options. Excessive blood loss is a common complication of this procedure. We evaluated whether use of an electrothermal bipolar coagulator (LigaSure Atlas, ValleyLab, Boulder, Colorado, USA) during pelvic exenteration is safe and whether it reduces intraoperative blood loss, intraoperative blood transfusion requirements, and length of hospital stay. Methods.: Between September 2003 and January 2005, 12 patients underwent pelvic exenteration (total, anterior, or posterior) performed using the electrothermal bipolar coagulator. Estimated blood loss, transfusion requirements, length of hospital stay, and complications necessitating reoperation were evaluated. Results.: The mean age was 55 years (range, 30-77), the mean estimated blood loss was 1931 ml (range, 1300-1500 ml), the mean number of units of packed red blood cells transfused intraoperatively was 3.4 U (range, 2-12 U), the mean operative time was 609 min (range, 400-940 min), and the mean length of hospital stay was 19.9 days (range, 7-27). There were no intraoperative complications related to the electrothermal bipolar coagulator use. None of the patients had any complications necessitating reoperation. Conclusions.: Use of the electrothermal bipolar coagulator device during pelvic exenteration is safe and may decrease blood loss and the number of units of blood that must be transfused intraoperatively.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 534-536 |
| Number of pages | 3 |
| Journal | Gynecologic Oncology |
| Volume | 102 |
| Issue number | 3 |
| DOIs | |
| State | Published - Sep 2006 |
| Externally published | Yes |
Fingerprint
Keywords
- Pelvic exenteration
- Surgical technique
ASJC Scopus subject areas
- Obstetrics and Gynecology
- Oncology
Cite this
Electrothermal bipolar coagulation for pelvic exenterations. / Slomovitz, Brian; Ramirez, Pedro T.; Frumovitz, Michael; Soliman, Pamela T.; Bevers, Michael; Coleman, Robert L.; Levenback, Charles.
In: Gynecologic Oncology, Vol. 102, No. 3, 09.2006, p. 534-536.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Electrothermal bipolar coagulation for pelvic exenterations
AU - Slomovitz, Brian
AU - Ramirez, Pedro T.
AU - Frumovitz, Michael
AU - Soliman, Pamela T.
AU - Bevers, Michael
AU - Coleman, Robert L.
AU - Levenback, Charles
PY - 2006/9
Y1 - 2006/9
N2 - Objectives.: The morbidity associated with pelvic exenteration is high; however, patients undergoing this procedure have no other curative treatment options. Excessive blood loss is a common complication of this procedure. We evaluated whether use of an electrothermal bipolar coagulator (LigaSure Atlas, ValleyLab, Boulder, Colorado, USA) during pelvic exenteration is safe and whether it reduces intraoperative blood loss, intraoperative blood transfusion requirements, and length of hospital stay. Methods.: Between September 2003 and January 2005, 12 patients underwent pelvic exenteration (total, anterior, or posterior) performed using the electrothermal bipolar coagulator. Estimated blood loss, transfusion requirements, length of hospital stay, and complications necessitating reoperation were evaluated. Results.: The mean age was 55 years (range, 30-77), the mean estimated blood loss was 1931 ml (range, 1300-1500 ml), the mean number of units of packed red blood cells transfused intraoperatively was 3.4 U (range, 2-12 U), the mean operative time was 609 min (range, 400-940 min), and the mean length of hospital stay was 19.9 days (range, 7-27). There were no intraoperative complications related to the electrothermal bipolar coagulator use. None of the patients had any complications necessitating reoperation. Conclusions.: Use of the electrothermal bipolar coagulator device during pelvic exenteration is safe and may decrease blood loss and the number of units of blood that must be transfused intraoperatively.
AB - Objectives.: The morbidity associated with pelvic exenteration is high; however, patients undergoing this procedure have no other curative treatment options. Excessive blood loss is a common complication of this procedure. We evaluated whether use of an electrothermal bipolar coagulator (LigaSure Atlas, ValleyLab, Boulder, Colorado, USA) during pelvic exenteration is safe and whether it reduces intraoperative blood loss, intraoperative blood transfusion requirements, and length of hospital stay. Methods.: Between September 2003 and January 2005, 12 patients underwent pelvic exenteration (total, anterior, or posterior) performed using the electrothermal bipolar coagulator. Estimated blood loss, transfusion requirements, length of hospital stay, and complications necessitating reoperation were evaluated. Results.: The mean age was 55 years (range, 30-77), the mean estimated blood loss was 1931 ml (range, 1300-1500 ml), the mean number of units of packed red blood cells transfused intraoperatively was 3.4 U (range, 2-12 U), the mean operative time was 609 min (range, 400-940 min), and the mean length of hospital stay was 19.9 days (range, 7-27). There were no intraoperative complications related to the electrothermal bipolar coagulator use. None of the patients had any complications necessitating reoperation. Conclusions.: Use of the electrothermal bipolar coagulator device during pelvic exenteration is safe and may decrease blood loss and the number of units of blood that must be transfused intraoperatively.
KW - Pelvic exenteration
KW - Surgical technique
UR - http://www.scopus.com/inward/record.url?scp=33748462440&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33748462440&partnerID=8YFLogxK
U2 - 10.1016/j.ygyno.2006.01.013
DO - 10.1016/j.ygyno.2006.01.013
M3 - Article
VL - 102
SP - 534
EP - 536
JO - Gynecologic Oncology
JF - Gynecologic Oncology
SN - 0090-8258
IS - 3
ER -